Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer crawled time : 12:05 save search
Aileron Therapeutics Announces Enrollment Expansion for Upcoming Phase 1b Clinical Trial of ALRN-6924 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Published: 2021-03-02 (Crawled : 12:05) - globenewswire.com
ALRN | $4.88 2.74% 2.66% 100K
|
Health Technology
|
| O: -0.6%
H: 2.41%
C: -7.23%
lung cancer phase 1 expansion cancer trial phase 1b phase 2b enroll
Veru Expands Oncology Drug Pipeline; Exclusively Licenses Phase 3 Clinical Stage Targeted Therapy for Endocrine Resistant Metastatic Breast Cancer
Published: 2020-12-09 (Crawled : 12:05) - globenewswire.com
VERU | $1.325 3.92% 3.77% 1.5M
|
Health Technology
|
| O: 2.0%
H: 28.31%
C: 17.52%
breast cancer license cancer therapy endocrine drug phase 3 metastatic breast cancer
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.